Utah Medical Products, Inc.UTMDNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P41
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -2.51% |
| Q3 2025 | -13.68% |
| Q2 2025 | 0.23% |
| Q1 2025 | 4.79% |
| Q4 2024 | -18.55% |
| Q3 2024 | 3.19% |
| Q2 2024 | -12.71% |
| Q1 2024 | -7.70% |
| Q4 2023 | 8.92% |
| Q3 2023 | -6.31% |
| Q2 2023 | -0.33% |
| Q1 2023 | -7.49% |
| Q4 2022 | 6.43% |
| Q3 2022 | 4.31% |
| Q2 2022 | 16.10% |
| Q1 2022 | -14.47% |
| Q4 2021 | -1.76% |
| Q3 2021 | 22.77% |
| Q2 2021 | 13.29% |
| Q1 2021 | -11.37% |
| Q4 2020 | 16.33% |
| Q3 2020 | 123.38% |
| Q2 2020 | -58.18% |
| Q1 2020 | -27.95% |
| Q4 2019 | 17.62% |
| Q3 2019 | 5.11% |
| Q2 2019 | 12.30% |
| Q1 2019 | -7.49% |
| Q4 2018 | -49.82% |
| Q3 2018 | 56.96% |
| Q2 2018 | 5.28% |
| Q1 2018 | 262.25% |
| Q4 2017 | -169.63% |
| Q3 2017 | -6.41% |
| Q2 2017 | 9.45% |
| Q1 2017 | 30.14% |
| Q4 2016 | -7.43% |
| Q3 2016 | -9.94% |
| Q2 2016 | 1.31% |
| Q1 2016 | 0.19% |